Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit

Journal of Ethnopharmacology

Volumn 115, Issue 2, 2008, Pages 217-222

  Fang, Zhi yuan ^a   Lin, Rong ^a   Yuan, Bing xiang ^a   Yang, Guang De ^a   Liu, Yu ^a   Zhang, Hui ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

CD40; MDA; MMP 2; SOD; Tanshinone IIA

Indexed keywords

CD40 ANTIGEN; GELATINASE A; MALONALDEHYDE; SALVIA MILTIORRHIZA EXTRACT; SUPEROXIDE DISMUTASE; TANSHINONE; TANSHINONE IIA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; INFLAMMATION; LIPID DIET; MALE; NONHUMAN; OXIDATIVE STRESS; PHARMACODYNAMICS; RABBIT; SALVIA MILTIORRHIZA; SPECTROPHOTOMETRY; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD40; ANTIOXIDANTS; ATHEROSCLEROSIS; DIETARY FATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 2; PHENANTHRENES; PLANT ROOTS; RABBITS; SALVIA MILTIORRHIZA; SUPEROXIDE DISMUTASE;

ANIMALIA; ORYCTOLAGUS CUNICULUS; SALVIA MILTIORRHIZA;

EID: 37249061594     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.09.025     Document Type: Article

References (34)

1. Chen Y.L., Yang S.P., Shiao M.S., Chen J.W., and Lin S.J. Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits. Journal of Cellular Biochemistry 83 (2001) 484-493
2. Esther L., Leonid G., Mat J.A.P.D., Ebo D.D.M., Iqbal S.G., Victor E.K., and Richard A.F. Requirement for CD154 in the progression of atherosclerosis. Nature Medicine 5 (1999) 1313-1316
3. Fu J., Huang H., Liu J., Pi R., Chen J., and Liu P. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. European Journal of Pharmacology 568 (2007) 213-221
4. Kehry M.R. CD40-mediated signaling in B cells, balancing cell survival, growth, and death. Journal of Immunology 156 (1996) 2345-2348
5. Kita T., Kume N., and Minami M. Role of oxidized LDL in atherosclerosis. Annals of the New York Academy of Sciences 947 (2001) 199-205
6. Li Z.T., Yang B.J., and Ma G.E. Chemical studies of Salvia miltiorrhiza f. alba. Yao Xue Xue Bao 26 (1991) 209-213
7. Liang Y., Yang Y.M., and Yuan S.L. Studies on pharmic mechanism and clinic application of Tanshinone. Traditional Herbal Drugs 31 (2000) 304-306
8. Libby P., Geng Y.J., Sukhova G.K., Simon D.I., and Lee R.T. Molecular determinants of atherosclerotic plaque vulnerability. Annals of the New York Academy of Sciences 811 (1997) 134-145
9. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
10. Lin T.J. Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardiotoxic action of adriamycin. Sheng Li Ke Xue Jin Zhan 22 (1991) 342-345
11. Lin R., Liu J.T., Gan W.J., Yang G.D., and Wang W.R. C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells. Biological and Pharmaceutical Bulletin 27 (2004) 1537-1543
12. Lin R., Liu J.T., Peng N., Yang G.D., Gan W.J., and Wang W.R. Lovastatin reduces nuclear factor κB activation induced by C-reactive protein in human vascular endothelial cells. Biological and Pharmaceutical Bulletin 28 (2005) 1630-1634
13. Lin R., Wang W.R., Liu J.T., Yang G.D., and Han C.J. Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. Journal of Ethnopharmacology 108 (2006) 217-222
14. Lin R., Yang G.D., Wang W.R., Liu J.T., He L.C., Peng N., and Han C.J. Screening the active components of Salvia miltiorrhiza for atherosclerosis with chromatography of CD40 highly expressed cell membrane. Journal of Chinese Medicinal Materials 29 (2006) 1325-1327
15. Lv B.Q., Fan Y.C., and Sun L.S. The influence of salvianolic acid B and tanshinone IIA on the nitric oxide and triglyceride in sera of atherosclerosis rabbit. Journal of Tianjin University of Traditional Chinese Medicine 25 (2006) 32-34
16. May A.E., Kalsch T., Massberg S., Herouy Y., Schmidt R., and Gawaz M. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106 (2002) 2111-2117
17. Nathalie A., Françoise M.S., Meyer E., Jean-Claude T., Axel W., Shigeyoshi I., Hans-Willi K., Robert S., and Anne N.S. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110 (2004) 571-578
18. Niu X.L., Ichimori K., Yang X., Hirota Y., Hoshiai K., Li M., and Nakazawa H. Tanshinone IIA inhibits low density lipoprotein oxidation in vitro. Free Radical Research 33 (2000) 305-312
19. Onitsuka M., Fujiu M., Shinma N., and Marutama H. New platelet aggregation inhibitors from Tan-Shen; Radix of Sal6ia miltiorrhiza BUNGE. Chemical Pharmaceutical Bulletin 31 (1983) 1670-1675
20. Park H.J., Lee S.B., Lee E., Cha B.C., Choi M.Y., Lee S.M., and Chung W.T. GC-MS analysis of diterpene quinone constituents of salviae miltiorrhiza radix and biological activity. Journal of Korean Society of Food and Nutrition 24 (1995) 459-465
21. Robert V., and Hideaki N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Circulation Research 92 (2003) 827-839
22. Romanic A.M., and Madri J.A. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. Journal of Cell Biology 125 (1994) 1165-1178
23. Ross R. Atherosclerosis: an inflammatory disease. The New England Journal of Medicine 340 (1999) 115-126
24. Schonbeck U., Sukhova G.K., Shimizu K., Mach F., and Libby P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 7458-7463
25. Schonbeck U., and Libby P. CD40 signaling and plaque instability. Circulation Research 89 (2001) 1092-1103
26. Tang F., Wu X., Wang T., Wang P., Li R., Zhang H., Gao J., Chen S., Bao L., Huang H., and Liu P. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascular Pharmacology 46 (2007) 427-438
27. Wang W.R., Lin R., Peng N., and Han C.J. The protective effects of tanshinone II A on vascular endothelial cells injury induced by hydrogen peroxide. Journal of Chinese Medicinal Materials 29 (2006) 53-55
28. Yasunori S., Chie S., Naoyasu M., Masafumi T., Naoko K., Samon K., Seizaburo K., and Jun H. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka Atherosclerosis Trial (FAST). Journal of the American College of Cardiology 39 (2002) 610-616
29. Zhan C.Y., Tao X.L., Tian C., Xiong W., and Zheng Z. Relationship between intercellular adhesion molecule-1 and hypertensive left ventricular hypertrophy and the effect of tanshinone IIA on expression of intercellular adhesion molecule-1. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 11 (2004) 208-211
30. Zhan C., Tao X., Tian C., Xiong W., and Zheng Z. Expression of intercellular adhesion molecule-1 in the development of hypertensive left hypertrophy and inhibitory effect of tanshinone II A. Chinese Journal of Clinical Rehabilitation 9 (2005) 254-256
31. Zhou G.Y., Jiang W., Zhao Y., Ma G.E., Xin W.J., Yin J.J., and Zhao B.L. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochemical Pharmacology 65 (2003) 51-57
32. Zhou G.T., Zhao G.F., and Fan Y.C. Effect of tanshinone IIA on expression of MCP-1 and IL-1 in injured smooth muscle cell induced by TNF-α. Tianjin Journal of Traditional Chinese Medicine 23 (2006) 189-191
33. Zhou L., Zuo Z., and Chow M.S. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 45 (2005) 1345-1359
34. Zorina S.G., and Jaikirshan J.K. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research 90 (2002) 251-262